You have 9 free searches left this month | for more free features.

metabolic dysfunction

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH) Trial

Enrolling by invitation
  • Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
  • Metabolic Associated-dysfunction Steatohepatitis (MASH)
  • Standard of care acceptance-based behavioral weight loss program
  • Occupational therapy dietary and lifestyle modifications
  • Wyoming, Michigan
    Gastroenterology Associates of Western Michigan, PLC
Nov 2, 2023

Hypertriglyceridemia Trial (MAR001, Placebo)

Not yet recruiting
  • Hypertriglyceridemia
  • (no location specified)
May 31, 2023

Schizophrenia, Healthy Trial (Intranasal insulin, Placebo)

Not yet recruiting
  • Schizophrenia
  • Healthy
  • Intranasal insulin
  • Placebo
  • (no location specified)
Feb 28, 2023

Polycystic Ovary Syndrome, Weight Gain, HbA1c Trial in Karachi (Empagliflozin 10 MG, MetFORMIN 500 Mg Oral Tablet)

Recruiting
  • Polycystic Ovary Syndrome
  • +2 more
  • Empagliflozin 10 MG
  • MetFORMIN 500 Mg Oral Tablet
  • Karachi, Sindh, Pakistan
    SINA Yousuf Sb Goth
Nov 28, 2023

Metabolic Dysfunction and Mucus Plugging on Asthma Physiology

Recruiting
  • Asthma
    • San Francisco, California
      UCSF Airway Clinical Research Center
    Feb 23, 2023

    Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

    Not yet recruiting
    • Fatty Liver, Nonalcoholic
    • SGLT2 inhibitor
    • (no location specified)
    Oct 31, 2023

    NMR-based Metabolic Profiling Identifies High Risk of MAFLD

    Not yet recruiting
    • Metabolic Dysfunction-associated Fatty Liver Disease
    • Metabolic Disease
    • NMR-based metabolic profiling
    • Wuhan, Hubei, China
      Tongji hospital, Tongji Medical College, Huazhong University of
    Feb 8, 2023

    Asthma, Obesity Trial in Durham, Burlington (Mitoquinol, Placebo oral tablet)

    Recruiting
    • Asthma
    • Obesity
    • Durham, North Carolina
    • +1 more
    Jan 26, 2023

    Schizophrenia, Metabolic Disturbance, Eating Behavior Trial (accelerated theta burst stimulation)

    Recruiting
    • Schizophrenia
    • +3 more
    • accelerated theta burst stimulation
    • Sham stimulation
    • Changsha, Hunan, China
      Second Xiangya Hospital Central South University
    Nov 17, 2022

    hsCAR and MAFLD: A Cross-sectional Study

    Recruiting
    • Metabolic Dysfunction-associated Fatty Liver Disease
    • +2 more
    • high-sensitivity C-reactive protein to albumin ratio
    • Chongqing, Chongqing, China
      The Second Affiliated Hospital of Chongqing Medical University
    Aug 2, 2023

    Diabetes Type 2 Trial in Sherbrooke (Bariatric surgery, Nicotinic Acid)

    Not yet recruiting
    • Diabetes Mellitus Type 2
    • Bariatric surgery
    • Nicotinic Acid
    • Sherbrooke, Quebec, Canada
      centre de recherche du CHUS
    Jun 27, 2023

    Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

    Recruiting
    • Fatty Liver Disease
    • Fibrotouch
    • Beijing, Bejing, China
      Bejing Tsinghua Chang Gung Hospital
    Jun 13, 2022

    Fatty Liver Trial in Naples

    Completed
    • Fatty Liver
      • Naples, Italy
        University of Campania Luigi Vanvitelli
      Mar 27, 2023

      Fatty Liver Disease Trial in Cheras (Intermittent Fasting)

      Recruiting
      • Fatty Liver Disease
      • Intermittent Fasting
      • Cheras, Kuala Lumpur, Malaysia
        Hospital Canselor Tuanku Muhriz
      May 19, 2023

      Metabolic Dysfunction-Associated Fatty Liver Disease, Obesity, Adolescent, Arterial Stiffness Trial in León (L-citrulline,

      Enrolling by invitation
      • Metabolic Dysfunction-Associated Fatty Liver Disease
      • +2 more
      • L-citrulline
      • +2 more
      • León, Guanajuato, Mexico
        Universidad de Guanajuato
      Mar 24, 2023

      Metabolic Dysfunction-associated Fatty Liver Disease, Cirrhosis Trial (Pioglitazone metformin tablets, Other drugs, Drug-free)

      Not yet recruiting
      • Metabolic Dysfunction-associated Fatty Liver Disease
      • Cirrhosis
      • Pioglitazone metformin tablets
      • +2 more
      • (no location specified)
      Nov 15, 2023

      Fatty Liver, NAFLD Trial (Coenzyme Q10 Forte® capsules)

      Not yet recruiting
      • Fatty Liver
      • NAFLD
      • Coenzyme Q10 Forte® capsules
      • (no location specified)
      Aug 8, 2023

      Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

      Recruiting
      • Metabolic Associated Fatty Liver Disease
      • LUDLEV®300 mg/46.2 mg
      • Placebo
      • Mexico, Veracruz, Mexico
        Ana Delfina Cano Contreras
      Jun 12, 2023

      Metabolic Associated Fatty Liver Disease in Chinese Population

      Completed
      • Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Nov 13, 2022

        Psoriasis, Metabolic Syndrome, Erectile Dysfunction Trial in Giza (lifestyle modification (exercise and control of diet))

        Recruiting
        • Psoriasis
        • +2 more
        • lifestyle modification (exercise and control of diet)
        • Giza, Egypt
          Cairo Unoversity
        Nov 20, 2022

        Metabolic Syndrome, Coronary Microvascular Dysfunction Trial in Baltimore (Vericiguat, Placebo)

        Not yet recruiting
        • Metabolic Syndrome
        • Coronary Microvascular Dysfunction
        • Baltimore, Maryland
          Johns Hopkins Hospital
        Jan 25, 2023

        Diagnostic Biomarkers for MAFLD Using Machine Learning Methods

        Active, not recruiting
        • Metabolic Dysfunction-associated Fatty Liver Disease
          • Hangzhou, Zhejiang, China
            The First Clinical Medical College of Zhejiang Chinese Medical U
          Sep 25, 2023

          Polycystic Ovary Syndrome Trial in Birmingham (oral androgen challenge with dehydroepiandrosterone (DHEA))

          Recruiting
          • Polycystic Ovary Syndrome
          • oral androgen challenge with dehydroepiandrosterone (DHEA)
          • Birmingham, West Midlands, United Kingdom
            Institute of Metabolism and Systems Research
          Feb 8, 2022

          Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens

          Recruiting
          • Nonalcoholic Steatohepatitis (NASH)
          • Metabolic Dysfunction-associated Steatohepatitis (MASH)
          • Hialeah Gardens, Florida
            Site #430
          Nov 1, 2023

          Mild Cognitive Impairment, Alzheimer, Hyperglycemia Trial (Coenzyme Q10, Placebo)

          Not yet recruiting
          • Mild Cognitive Impairment
          • +3 more
          • Coenzyme Q10
          • Placebo
          • (no location specified)
          Sep 10, 2023